Clinical Trial Update: Comparison Between iLux and LipiFlow in the Treatment of Meibomian Gland Dysfunction (MGD): A 12-month, Multicenter Study [NA]

View source ↗

Summary

A completed multicenter trial comparing iLux and LipiFlow for Meibomian Gland Dysfunction and evaporative dry eye disease; full results were posted in 2021.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Evaporative Dry Eye Disease
• Meibomian Gland Dysfunction

Drugs mentioned

• LipiFlow
• iLux

Snippet

Sponsor: Alcon Research | Conditions: Meibomian Gland Dysfunction, Evaporative Dry Eye Disease | NA | Status: COMPLETED | Results posted: 2021-10-08